Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD): A Cohort for Dementia Research and Ethnic-Specific Insights
10.12779/dnd.2024.23.4.212
- Author:
Hyemin JANG
1
;
Daeun SHIN
;
Yeshin KIM
;
Ko Woon KIM
;
Juyoun LEE
;
Jun Pyo KIM
;
Hee Jin KIM
;
Soo Hyun CHO
;
Si Eun KIM
;
Duk. L. NA
;
Sang Won SEO
;
On behalf of the K-ROAD Study Groups
Author Information
1. Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
- Publication Type:Original Article
- From:Dementia and Neurocognitive Disorders
2024;23(4):212-223
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:and Purpose: Dementia, particularly Alzheimer’s disease, is a significant global health concern, with early diagnosis and treatment development being critical goals. While numerous cohorts have advanced dementia research, there is a lack of comprehensive data on ethnic differences, particularly for the Korean population. The Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD) aims to establish a large-scale, hospital-based dementia cohort to address this gap, with a focus on understanding disease progression, developing early diagnostics, and supporting treatment advancements specific to the Korean population.
Methods:K-ROAD comprises multiple prospective cohorts. Participants underwent clinical evaluations, neuroimaging, and biomarker analysis, with data collected on a range of clinical and genomic markers.
Results:As of December 2023, K-ROAD has recruited over 5,800 participants, including individuals across the Alzheimer’s clinical syndrome, subcortical vascular cognitive impairment, and frontotemporal dementia spectra. Preliminary findings highlight significant ethnic differences in amyloid positivity, cognitive decline, and biomarker profiles, compared to Western cohorts.
Conclusions:The K-ROAD cohort offers a unique and critical resource for dementia research, providing insights into ethnic-specific disease characteristics and biomarker profiles. These findings will contribute to the development of personalized diagnostic and therapeutic approaches to dementia, enhancing global understanding of the disease.
